{
    "2021-02-03": [
        [
            {
                "time": "",
                "original_text": "长城证券----金域医学：业绩表现持续亮眼，新冠检测推动高增长【公司研究】",
                "features": {
                    "keywords": [
                        "金域医学",
                        "业绩表现",
                        "新冠检测",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物2月月报：寻业绩主线 重点关注CXO等高增长赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩主线",
                        "CXO",
                        "高增长赛道"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}